Zhang, Jia
Liu, Cong
Peng, Ying
Fang, Qianhua
Wei, Xing
Zhang, Cui
Sun, Lin
Hu, Zhuomeng
Hong, Jie
Gu, Weiqiong
Wang, Weiqing
Shi, Juan
Zhang, Yifei
Funding for this research was provided by:
the Shanghai Medical and Health Development Foundation (no. DMRFP_II_05, no. DMRFP_II_01)
“Management strategy of the tertiary prevention and treatment of diabetes based on DIP system” supported by China Health Promotion Foundation
the Capacity building for multidisciplinary cooperation in diagnosis and treatment of major metabolic diseases (no. Z155080000004)
Innovative research team of high-level local universities in Shanghai
the National Natural Science Foundation of China (no. 82270896)
Article History
Received: 11 October 2023
Accepted: 1 January 2024
First Online: 11 January 2024
Declarations
:
: The study protocol was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. This study was carried out in strict compliance with the principles of the Declaration of Helsinki. All participants signed the written informed consent.
: Not applicable.
: The authors declare no competing interests.